Background: Ribosome biogenesis protein BRX1 homolog (BRIX1) is a vital member for synthesizing 60S subunit of ribosome. However, the role and mechanism of BRIX1 in colorectal cancer (CRC) are still unclear. Methods: KEGG pathway analysis and Gene Ontology (GO) analysis were used for bioinformatics analysis. Ribosome RNAs (rRNAs) levels were detected in CRC tissues and cells. Nascent RNA synthesis were detected by cellular immunofluorescence. Correlation was analysis between PET-CT value and BRIX1 expression. Extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) were conducted by seahorse analyses. Polysome fractions were collected for BRIX1 mRNA used in translation. Orthotopic model and CCK-8 assay were used for BRIX1 function in CRC.Results: We found that BRIX1 is a core gene of ribosome-related pathway changes in CRC. GO analysis showed BRIX1 primarily enriched RIBOSOME ASSEMBLY and RIBOSOME BIOGENESIS pathways. In fresh CRC tissue, rRNAs levels (5S, 5.8S, 18S and 28S) were obvious higher in BRIX1-high group than BRIX1-Low group. Similarly, BRIX1 knockdown and overexpression significantly dereased and increased rRNAs levels (5S, 5.8S, 18S and 28S) in CRC cells, respectively. In addition, BRIX1 knockdown inhibited nascent RNA synthesis of CRC cells. In clinical data analysis, we found that BRIX1 expression is related to the glucose uptake of PET-CT. Consistently, BRIX1 knockdown and overexpression significantly dereased and increased ECAR valve, glucose uptake and lactic acid production in CRC cells. Subsequently, we found BRIX1 knockdown and overexpression significantly dereased and increased the protein expression of GLUT1, but not affect its mRNA expression. Interestingly, we found BRIX1 knockdown and overexpression obviously decreased and increased mRNA level of GLUT1 in polysome fractions. Blocking glycolysis by si-GLUT1 or galactose reversed the promoting role of BRIX1 in glycolysis and cell proliferation of CRC cells. Conclusion: In this study, BRIX1 plays a tumor-promoting role in CRC via regulating glycolysis by selecting GLUT1 translation, indicating a correlation between ribosome activation and metabolic reprogramming in CRC.